Table 1.

Clinical features of patient cohort

Group	HCC (n = 120)	Cirrhosis (n = 120)
Sex (M/F)	96/24	88/32
Age (year)	55.4 ± 11.4	50.9 ± 12.6
HBsAg (+)	100	106
AFP	17580.8 ± 100941.3	24.5 ± 90.8
<20 ng/mL (%)	37 (30.8%)	94 (78.3%)
20–400 ng/mL (%)	28 (23.3%)	25 (20.8%)
≥400 ng/mL (%)	55 (45.8%)	1 (0.8%)
Tumor stage (I/II/III/IV)	46/36/38/0	NA

n number, HBsAg (+) hepatitis B virus antigen positive, AFP alpha-fetoprotein, NA not applicable

Note: All data are presented as mean ± SD